First human tests begin for new eli lilly compound
NCT ID NCT06690996
Summary
This is an early safety study testing a new drug called LY4005130 in healthy volunteers. Researchers want to see what side effects might occur and how the drug moves through the body. The study involves giving single and multiple doses to small groups of healthy people and closely monitoring them.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.